Related by context. All words. (Click for frequent words.) 65 binary restenosis 63 angiographic outcomes 63 segment binary restenosis 62 XIENCE V demonstrated 61 Drug eluting stent 61 TAXUS Stent 61 diameter stenosis 60 ARCALYST ® 60 XIENCE V PROMUS Stent 59 deep venous thromboses 59 angiographic restenosis 59 mm Stent 58 Stent thrombosis 58 TAXUS Liberte Long 58 TAXUS Express Stent 58 stent thromboses 58 postprocedure 58 spinal nonfusion 58 definite stent thrombosis 58 repeat revascularization 58 workhorse lesions 57 serum aminotransferase levels 57 drug eluting coronary stents 57 PDP MLR 57 recurrent ischemia 57 PLX STROKE targeting 57 recurrent myocardial infarction 57 Cypher Sirolimus 57 renarrowing 56 reinfarction 56 restenosis reblockage 56 underwent percutaneous coronary 56 receiving prophylactic anticoagulation 56 TAXUS p value 56 ICD implants 56 XIENCE V vs. 56 PASI scores 56 ARCOXIA 56 preventing restenosis 56 MVAS gross 56 stented 56 aspirin clopidogrel 56 cerebral somatic oximeter 56 non valvular atrial 56 perioperative mortality 56 unstable angina pectoris 56 Erythropoietic therapies may 56 valdecoxib 56 Known hypersensitivity 55 failure TVF 55 percutaneous intervention 55 noninvasive outpatient 55 Taxus Stent 55 PROMUS Element 55 paroxysmal AF 55 intravascular ultrasonography 55 quantitative coronary angiography 55 postoperative atrial fibrillation 55 reduce serum phosphate 55 Coronary Artery Bypass Graft 55 dose pravastatin 55 postoperative morbidity 55 recurrent atrial fibrillation 55 wound dehiscence 55 sirolimus eluting 55 CYPHER Stent 55 urinary N telopeptide 55 thrombotic events 55 invasive aspergillosis 55 ventricular tachyarrhythmia 55 revascularized 55 XIENCE V stent 55 SilverHawk Plaque Excision System 55 MoxDuo TM IR 55 reblockage 55 CABG surgeries 55 morphometric vertebral fractures 55 rebleeding 55 dalteparin 55 inhospital mortality 55 malignancy HCM 55 Coronary artery bypass graft 55 undergoing coronary artery 54 TAXUS Express 54 nonvertebral fracture 54 ximelagatran 54 Flow NIW 54 recurrent VTE 54 venous thromboembolic disease 54 undergoing percutaneous coronary 54 coronary artery bypass grafts 54 revascularizations 54 STRIDE PD 54 low dose Iluvien 54 paclitaxel eluting stent 54 receiving XGEVA 54 elevation acute coronary 54 Renal impairment 54 detectable HCV RNA 54 Paraplatin 54 prolonged QT interval 54 carotid artery blockage 54 Cypher Stent 54 gluteal injection 54 NAVISTAR R 54 concomitant antibiotics 54 prospectively stratified 54 NATRECOR ® 54 placebo dexamethasone 54 events MACE 54 DES implantation 54 statins Lipitor Zocor 54 circulating EPCs 54 Tumors shrank 54 HBeAg seroconversion 54 Complication rates 54 FQ = fiscal 54 S. aureus sepsis 54 Adjusted EBITDAR margin 54 periprocedural 54 postoperative infections 54 restenosis 54 arterial thromboembolic events 54 inhospital 54 silent ischemia 54 stented vessel 54 thromboembolic events 54 oxycodone CR 54 Transcatheter aortic valve implantation 54 Warfarin Coumadin 54 SORT OUT III 54 atherothrombotic events 54 ZoMaxx 54 stent binary restenosis 54 sirolimus eluting stent 54 Recreational Accessories 54 ischemia driven 54 TAXUS Liberté stent 54 abdominal abscess beginning 53 target lesion revascularization 53 TAXUS Element Stent 53 Abbott bioabsorbable everolimus eluting 53 systemic embolism 53 refractory ischemia 53 postoperative mortality 53 Operative mortality 53 DEFICIT REDUCTION CBO 53 severe exacerbations 53 KRAS mutations occur 53 saphenous vein graft 53 bifurcated lesions 53 mitral regurgitation MR 53 Taxus Express2 53 PSADT 53 TAXUS stent 53 enoxaparin sodium 53 FluCAM arm 53 stent restenosis 53 carotid artery stenting CAS 53 symptomatic intracranial 53 Procrit Eprex 53 sustained ventricular tachycardia 53 anginal pain 53 reoperations 53 patients undergoing percutaneous 53 upper endoscopies 53 naïve HCV 53 achieved ACR# 53 sirolimus eluting stents 53 MitraClip device 53 intravascular hemolysis 53 TriActiv System 53 Postoperative complications 53 uncoated stent 53 haematologic 53 undergo percutaneous coronary 53 allogeneic HSCT 53 related bloodstream infections 53 oral antidiabetes 53 statewide unadjusted jobless 53 pancreatic resection 53 target vessel revascularization 53 XIENCE V. 53 CYP#A# substrate 53 thrombotic complications 53 prioryear 53 Balloon Kyphoplasty 53 Adjusted EBIDTA 53 TAXUS 53 Hemorrhagic stroke 53 hepatorenal syndrome 53 Angiox ® 53 anthracycline taxane 53 intraoperative complications 53 torsemide ER 53 preintervention 53 Wireline adjusted EBITDA 53 ARB telmisartan 53 underwent CABG 53 surgical prophylaxis 53 infarction STEMI 53 Mg Usa 53 myocardial reperfusion 53 binary restenosis rate 53 ACTEMRA TM 53 postoperative delirium 53 onset sepsis 53 bovine thrombin 53 bone marrow reticulin 53 reinterventions 53 graft occlusion 53 Nonresidential structures 53 osteoporotic compression fractures 53 anaphylactic reactions bronchospasm 53 thromboembolism 53 iliac artery disease 53 Tasigna prolongs 53 patients undergoing noncardiac 53 anagrelide 52 atheroma volume 52 ischemic cardiomyopathy 52 TAXUS Liberte Stent 52 thoracic aortic 52 Targretin capsules 52 Non inferiority 52 CIMZIA ™ 52 theprior 52 glycated hemoglobin HbA1c 52 decompensated heart failure 52 anemia neutropenia 52 antiplatelet agent 52 neointimal hyperplasia 52 Isomedix Services 52 repeat paracentesis 52 patients undergoing CABG 52 beta blockers ACE inhibitors 52 serum BDNF 52 carotid artery stenting 52 Hip fracture 52 deCODE AF TM 52 Severity MSCS score 52 prostate TURP 52 ischemic complications 52 Adjusted EBITDA1 52 thrombectomy 52 intravenous cyclophosphamide 52 LV dysfunction 52 acute myocardial infarction AMI 52 Lupuzor ™ 52 accompanying electrolyte abnormalities 52 rt PA 52 catheter occlusion 52 recurrent glioblastoma multiforme 52 prednisone prednisolone plus 52 Events MACE 52 Edwards SAPIEN transcatheter 52 de novo lesions 52 thromboembolic complications 52 VT VF 52 rFVIIa 52 bezafibrate 52 unresectable HCC 52 reclog 52 intravascular ultrasound 52 nondiabetic patients 52 achieved CCyR 52 FUSILEV enhances 52 Kyle P. Macione 52 #.#/#.# mmHg [001] 52 bacteriuria 52 erythema nodosum 52 coronary stenting 52 ischemia acute myocardial 52 coronary revascularization 52 losartan Cozaar 52 acute STEMI 52 revascularisation 52 glomerular filtration 52 biologic antibody 52 venous hypertension 52 containing abacavir 52 clomipramine 52 Hypotension 52 carotid stent 52 ATACAND 52 hsCRP levels 52 defibrillator CRT D 52 Mg Uk 52 Programmer Paradise segment 52 Prepaid churn 52 antidepressants fluoxetine 52 everolimus eluting stents 52 comparedwith 52 malfunctioning pacemakers 52 ZOLINZA 52 plasma creatinine 52 upper gastrointestinal bleeding 52 Steel narrows 1Q 52 mineral density BMD 52 Abelcet 52 myocardial infarction ventricular fibrillation 52 lumen diameter 52 severe hypersensitivity reactions 52 ticlopidine 52 tachyarrhythmias 52 recurrent DVT 52 nadroparin 52 SunLink Specialty Pharmacy 52 intravesical therapy 52 TAVR 52 artery reclogging 52 symptomatic VTE 52 Sapien XT 52 Ejection fraction 52 angioplasty stenting 52 LNG IUS 51 Currency translation negatively impacted 51 percutaneous coronary interventions 51 Electro Rent NASDAQ ELRC 51 transcatheter aortic 51 FROVA 51 thromboembolic 51 coronary artery blockages 51 Segment adjusted OIBDA 51 coronary revascularization procedures 51 ascompared 51 pooled comparator 51 primary percutaneous coronary 51 dyslipidemia hypertension diabetes 51 postintervention 51 CCyR 51 Repliform R revenues 51 coronary intervention 51 ICD implantation 51 serum phosphorous 51 Pancreatic neuroendocrine tumors 51 cerebrovascular events 51 heparin induced thrombocytopenia 51 Percutaneous Transluminal Coronary Angioplasty 51 Retisert TM 51 pantoprazole 51 operatingincome 51 diabetic kidney 51 was#.# 51 Achieves Primary Endpoint 51 carotid endarterectomy CEA 51 IV bisphosphonates 51 sunitinib sorafenib 51 sirolimus stent 51 Carotid Revascularization Endarterectomy vs. 51 ACR# responses 51 intrathoracic 51 Ebstein anomaly 51 neurologic complications 51 perioperative complications 51 Celebrex celecoxib 51 bottom #.#pt 51 Tumor shrinkage 51 events TEAEs 51 inhibit platelet function 51 cardiac repolarization 51 TEB adjustment 51 microbiological eradication 51 LFQ gross 51 vertebral fracture 51 coronary stenosis 51 stage IIIb IV 51 Thalomid ® 51 colorectal liver metastases 51 Durable goods inventories 51 directed thrombolysis 51 coronary revascularisation 51 postoperative bleeding 51 postoperative sepsis 51 Zylet 51 tapentadol IR 51 atrial arrhythmias 51 Spectranetics laser 51 CLP#.# trillion 51 cardiovascular ischemic 51 Refinery utilization rebounded 51 microbiologically evaluable 51 venous stasis 51 tracer uptake 51 Intravenous immunoglobulin 51 Engineered Material Systems 51 edifoligide 51 Fasting blood glucose 51 hematological parameters 51 coxib 51 serum urate 51 Zometa hazard 51 CTEPH 51 HYVISC R 51 fibrinolytic therapy 51 mucocutaneous reactions 51 Urinary infections 51 oral hypoglycemic agent 51 combines Zetia 51 antibiotic Biaxin 51 ID TLR 51 complete cytogenetic response 51 sustained virologic response 51 underwent prostate biopsy 51 Projections ranged 51 Target Lesion Revascularization TLR 51 hemodynamically significant 51 sitaxsentan 51 underwent coronary angiography 51 Motorized RV 51 electrical cardioversion 51 CYPHER ® Stent 51 GDP deflator broad 51 WallFlex Biliary RX 51 Percutaneous Coronary Intervention 51 IELEC.T 51 Tambocor 51 baseline A1C 51 variceal 51 ended September# 51 intracerebral hemorrhages 51 bi ventricular pacing 51 NEVO ™ 51 paralytic ileus 51 death reinfarction 51 endarterectomy 51 thienopyridine 51 PRAVACHOL R 51 GVAX vaccine 51 patent ductus arteriosus PDA 51 virologic response 50 IOP lowering 50 hepatectomy 50 ipsilateral stroke 50 Procrit anemia drug 50 venous thromboembolic events 50 confirmed CCyR 50 nephrotoxicity 50 multivessel disease 50 CYPHER stent 50 underwent surgical resection 50 concurrent chemoradiation 50 Flextome 50 TAXUS Liberte stent 50 xanthine oxidase inhibitor 50 Commonly prescribed 50 Coronary artery bypass grafting 50 Cordis stent 50 Wellbutrin XL ® 50 antiplatelet medications 50 paclitaxel eluting stents 50 azilsartan medoxomil 50 got Abbott MitraClip 50 plus aztreonam 50 included exfoliative dermatitis 50 pulmonary dysfunction 50 mcg albinterferon alfa 2b 50 PRISTIQ 50 idraparinux 50 polypoid 50 achieved sustained virologic 50 from#.# [001] 50 risedronate sodium tablets 50 specific antigen PSA 50 reactogenicity 50 Annualized ROE 50 creatine kinase MB 50 TAXUS Element 50 stent insertion 50 severe mitral regurgitation 50 disposable TMR 50 Darapladib 50 endoleaks 50 mcg kg REBETOL 50 GERD symptom 50 coronary artery occlusion 50 Visiting Nurse VN 50 cediranib 50 nonproliferative 50 pegylated interferons 50 urgent coronary revascularization 50 endophthalmitis 50 carotid endarterectomy 50 Noninterest Expense Noninterest expense 50 tapentadol ER 50 EDARBI 50 Paliperidone ER 50 tirofiban 50 abacavir lamivudine 50 ReFacto 50 serotonin norepinephrine reuptake inhibitor 50 bypass graft CABG surgery 50 transfusion syndrome 50 Index CDAI score 50 TEAEs 50 Levaquin levofloxacin 50 hemorrhagic complications 50 revascularization procedure 50 Romaco segment 50 Zocor cholesterol lowering 50 NYHA Class II 50 glycoprotein IIb IIIa inhibitor 50 vi ineffectiveness 50 noninterest expense decreased 50 C diff infections 50 MACCE 50 stenting procedures 50 Crohn Disease Activity 50 prostate radical prostatectomy 50 ACR# ACR# 50 XOPENEX Inhalation Solution 50 Angiographic 50 Cardiac Surgery Systems 50 BeneFIX 50 advanced adenomas 50 cerebral vasospasm 50 Nesiritide 50 Roddick Petitbois 50 mg BID dose 50 lumbar spine bone 50 RAD SVT 50 plus COPEGUS 50 steroid refractory 50 infective endocarditis 50 cardiac resynchronization 50 approved incretin mimetic 50 nonobstructive CAD 50 Clinically significant 50 bronchial hyperresponsiveness 50 droperidol 50 LIDODERM 50 ventricular tachycardia VT 50 distal embolization thrombus formation 50 primary patency 50 dose dabigatran 50 nausea emesis 50 aldosterone antagonist 50 EXJADE 50 Thal Dex 50 underwent balloon angioplasty 50 NSTE ACS 50 Noninterest expense totaled 50 Amgen Neulasta R 50 discontinued Viread 50 plus prednisone prednisolone 50 demonstrated clinically meaningful 50 renal artery stenting 50 anthracycline containing 50 triglyceride concentrations 50 AGILECT R 50 rosiglitazone maleate 50 exhaled NO 50 eplerenone 50 Losartan 50 quinapril 50 expenses totaled Ps 50 recurrent tonsillitis 50 Cdn#.# cents per 50 mediated dilation 50 mycophenolic acid 50 postoperative hemorrhage 50 OshKosh wholesale 50 Major Adverse Cardiac 50 infarction NSTEMI 50 Evaporative Cooling segment 50 intima media thickness IMT 50 CABG coronary artery 50 discontinuations 50 ST elevation myocardial 50 nevirapine regimen 50 MARRIOTT REVENUES totaled 50 Known generically 50 virologic failure 50 Hemorrhagic strokes 50 fatigue abdominal pain 50 HBeAg positive patients 50 UA NSTEMI 50 potassium sparing 50 KRAS mutant tumors 50 coagulation parameters 50 GI bleeds 50 pT3 50 nonfood discretionary 50 Xelox 50 mL/min/#.# m2 50 anticholesterol 50 lumiliximab 50 function Langberg 49 hemoglobin A1c levels 49 Related Anemia 49 thinner struts 49 upon rechallenge 49 HIV treatments Reyataz 49 angina myocardial infarction 49 stent implantation 49 resuscitated cardiac arrest 49 mitral insufficiency 49 levosimendan 49 serum phosphate 49 FRAGMIN 49 colonoscopy detects precancerous polyps 49 Febrile neutropenia 49 vertebral compression fracture 49 myocardial infarction MI 49 mortgage fundings 49 #mg BID [001] 49 Resolute DES 49 A1PI 49 Environmental Filtration 49 Barocycler instruments 49 Ps.#.# [006] 49 Aceon 49 glycated hemoglobin levels 49 lumbar disk herniation 49 systemic corticosteroid 49 voiding dysfunctions 49 Variable annuity sales 49 Fibrillex TM 49 NATRECOR R 49 acute cholecystitis 49 undergone splenectomy 49 noninferior 49 PSA nadir 49 prescribed beta blocker 49 venous thromboembolisms 49 OPCAB 49 neutrophil counts 49 stented artery 49 Polymer Additives segment 49 postoperative complication 49 names Procrit Epogen 49 cardiovascular hospitalizations 49 CYP#D# inhibitor 49 Interest Expense Interest expense 49 abysmal Shaiken 49 Maxipime 49 Severe hypersensitivity reactions 49 unclog arteries 49 TAXUS Express Atom Stent 49 prolactin elevation 49 RVOT 49 amoxicillin clavulanate 49 fluoxetine HCl 49 death dissection perforation 49 left ventricular systolic 49 Aprovel R 49 Pro forma Adjusted EBITDA 49 mg kg Hematide 49 ARIXTRA 49 stent thrombosis blood clots 49 anastomotic leak 49 acute myocardial infarctions 49 Supervalu 3Q 49 noncardiac 49 intracranial hemorrhage ICH 49 NIASPAN 49 hemoglobin A1C HbA1C 49 Pharmacokinetic parameters 49 Myocardial Infarction Study 49 Generally Accepted Accounting Principle 49 severe hypoglycemic 49 KADIAN ® 49 sunitinib Sutent 49 biochemical recurrence 49 TRXFLDAXPU 49 intracranial bleeding 49 cardiovascular hospitalization 49 coronary interventions 49 lumbar spine BMD 49 oral diclofenac 49 tricuspid regurgitation 49 invasive fungal 49 advanced adenoma 49 infarct size 49 receiving SIMPONI 49 ADCS CGIC 49 BioGlue revenues 49 undetectable viral 49 GP IIb IIIa inhibitors 49 symptomatic carotid stenosis 49 renal biopsy 49 colon resection 49 Its ROA 49 Nasdaq adv dec 49 subtherapeutic 49 colon perforation 49 HBeAg negative patients 49 microkeratome blade 49 lipid lowering agents 49 simvastatin ezetimibe 49 resolves spontaneously 49 Specialty Engineered Alloys 49 antiarrhythmic drug 49 TNF antagonist 49 pulmonary artery banding 49 atorvastatin #mg 49 LTCHs 49 stenoses 49 combination estrogen progestin 49 multivariate adjustment 49 Medicare Advantage MLR 49 #compared 49 Incursions During 49 RBP4 levels 49 vintage subprime RMBS 49 Daniel Boulud truffle 49 gastrointestinal bleeds 49 angina pectoris 49 HealthGrades analyzed 49 underwent resection 49 R adefovir dipivoxil 49 Balloon angioplasty 49 Kaplan Meier estimates 49 Cymbalta duloxetine 49 balloon kyphoplasty 49 www.courier-journal.com/moss 49 stent thrombosis 49 Khyani bodyguard 49 recurrent venous thromboembolism 49 clopidogrel Plavix 49 noninferiority 49 DAS# CRP 49 oxycodone IR 49 tumor progression TTP 49 trabeculectomy 49 postoperative pulmonary 49 mcg QD 49 reintervention 49 BUPHENYL R sodium phenylbutyrate 49 thrombocytopenic 49 chlorambucil 49 plus gemcitabine 49 postoperative AF 49 valvular disease 49 plus GP IIb 49 acute ischemic stroke 49 recurrent GBM 49 Val HeFT 49 follicular lymphoma FL 49 recanalization 49 pruritus rash 49 Mortgage loan originations 49 intima media thickness 49 symptomatic hyponatremia 49 FOLFOX4 49 Carotid artery 49 antiandrogen 49 Sustained Virological Response 49 locoregional recurrence 49 neutropenic 49 nonfatal myocardial infarction MI 49 mainline passenger RASM 49 maximally tolerated lipid lowering 49 RLEC adjusted EBITDA 49 PRADAXA #mg 49 headache abdominal pain 49 Cimzia TM 49 unruptured aneurysm 49 paroxysmal supraventricular tachycardia 49 mineral density 49 reports Q3 adj 49 teriflunomide 49 acute coronary syndromes ACS 49 glycoprotein IIb IIIa inhibitors 49 TURBT 49 arteriolar 49 tolterodine ER 49 nonadherence 49 Irrigation Segment 49 overlapping stents 49 FHLB advances decreased 49 Captive colonies 49 Digoxin 49 hepatic liver 49 NSE Volatility Index 49 USD #.#bln [001] 49 achieved statistical significance 49 abnormal uterine bleeding 49 C4 Processing 49 SRTI leader 49 ThromCat XT 49 brachial artery flow 49 systemic hypotension 49 acute decompensation 49 CK MB 49 FOOTWEAR Down 49 OC ZIPs 49 thrombus aspiration 49 parecoxib 49 severe neutropenia 49 darbepoetin alfa Aranesp 49 lactate dehydrogenase LDH 49 infusional 49 Amgen anemia 49 obstructive coronary artery 49 CK # plasma concentrations 49 selective non steroidal 49 pancreatectomy 48 IV RSD# 48 mitral valve replacement 48 transcatheter closure 48 mediastinitis 48 Antibiotic prophylaxis 48 hemostatic efficacy 48 receiving INTRON 48 coronary artery bypass graft 48 biochemical relapse 48 QTc prolongation 48 basal insulins 48 atherothrombotic disease 48 pharmacokinetic equivalence 48 undergoing coronary angiography 48 plus prednisone 48 preterm newborns 48 REYATAZ r arm 48 stroke myocardial infarction 48 unfractionated heparin UFH 48 serum potassium 48 metformin monotherapy 48 nicardipine 48 HbA 1c levels 48 efficiency ratio teb 48 Corp. LTXX 48 alanine aminotransferase 48 acetabular fractures 48 ResCap GMAC mortgage 48 alfuzosin 48 FullTerm 48 cervicitis 48 Catapres 48 sustained virological response 48 achieved PASI 48 overyear 48 Scantron segment decreased 48 antiplatelet drugs 48 Selzentry TM 48 transthoracic 48 Retisert 48 CI #.#-#.# [001] 48 fullyear outturn represents 48 oncologic outcomes 48 FOLFIRI alone 48 infliximab monotherapy 48 CLABSIs 48 activated partial thromboplastin 48 MBCPO 48 aplastic anemia AA 48 oxymorphone ER 48 cyclophosphamide methotrexate 48 pravastatin therapy 48 Homocysteine levels 48 peripheral arterial occlusive disease 48 fraction LVEF 48 receiving FUSILEV 48 R0 resection 48 antirheumatic 48 endometrial thickness 48 myocardial infarctions 48 ADHD stimulant 48 Colorectal cancer incidence 48 Iberiabank NASDAQ IBKC 48 Starlix 48 eptifibatide Injection 48 biliary stent 48 kyphoplasty 48 Subgroup analysis 48 Lauren Petitbois 48 neointimal 48 obstructive CAD 48 anticoagulant warfarin 48 EBITD 48 classical orthosteric agonist 48 luminal diameter 48 NOXAFIL Oral Suspension 48 angiographic 48 elective percutaneous coronary 48 CRESTOR #mg 48 Countrywide loan fundings 48 rosuvastatin #mg 48 SVR# 48 Powerlink XL 48 TAXUS Liberte Atom Stent 48 infarctions 48 Dostinex 48 fluvastatin 48 parathyroidectomy 48 β blockers 48 Cystatin C 48 N telopeptide 48 PGP Acquisition 48 gout flares 48 Gabitril 48 Bextra valdecoxib 48 NP CRNs 48 NNT = 48 genital ulcer 48 elective PCI 48 Summarized consolidated 48 Halotron revenues 48 Rhetoric heats 48 Hypocalcemia 48 OPANA franchise 48 Coronary angiography 48 Index CDAI 48 segment elevation myocardial 48 Seasonally unadjusted 48 HER2 expression 48 Colorectal cancer screening 48 Nonperforming loans totaled 48 pulmonary capillary wedge 48 Halcyon Jets capitalizes 48 ICD shocks 48 liver resection 48 Trimmed Mean PCE 48 aneurysm ruptures 48 cilostazol 48 Herpes infections 48 Munghana Lonene Listenership 48 Intravitreal 48 acute myocardial infarction 48 C. difficile diarrhea 48 ICD implantations 48 pegylated interferon alpha 48 ertapenem 48 transabdominal 48 hemodynamically unstable 48 markup Tollin 48 Corp. SYK 48 elevated ALT 48 OSV segment 48 carboplatin chemotherapy 48 pulmonic valve 48 mitral valve regurgitation 48 MCyR 48 median survivals 48 Acute pancreatitis 48 desvenlafaxine succinate 48 Phosphates segment 48 CHD CVD 48 argatroban 48 STEMIs 48 plus dexamethasone 48 THERMOCOOL R 48 erythropoietins 48 quetiapine risperidone 48 Adalat CC 48 Gross Margin Gross 48 bps YoY 48 mRCC 48 calcified plaques 48 aminotransferases 48 venlafaxine hydrochloride 48 spokesman Steven Tragash 48 sonographically guided 48 metastatic GIST 48 #.#ng/ml 48 angiographic follow 48 drug eluting stent implantation 48 pacemakers stents 48 curative resection 48 Cardiolite 48 obstructed bile duct 48 mg QD 48 Real disposable incomes 48 unstable angina UA 48 bowel perforations 48 increased elevenfold 48 OUTLOOK Highlights 48 stents BMS 48 benign nodules 48 graft patency 48 Hemolytic uremic syndrome 48 needle electromyography procedures 48 MiStent DES 48 achieving PASI 48 tPA antithrombotics anticoagulation therapy 48 www.courier-journal.com/bobhill 48 platelet reactivity 48 radiotherapy radiosurgery 48 syncope fainting 48 aspartate aminotransferase AST 48 International Normalized Ratio 48 Optivar 48 Istalol 48 variceal bleeding 48 A1c levels 48 stable angina 48 glipizide plus 48 midstage clinical 48 thrombosed 48 nonselective NSAIDs 48 GP IIb IIIa inhibitor 48 Loss severities 48 atrioventricular valve 48 p = NS 48 cancerous colon polyps 48 hip BMD 48 bone marrow reticulin deposition 48 Fasting plasma glucose